57 Results for "

IRE1α

" in MedChemExpress (MCE) Product Catalog:
Products (57)

57 Results for "IRE1α" in MCE Product Catalog:

  • Targets Recommended:
111
111 Publications Verification
Cat. No.: HY-19696B
CAS No.: 117609-50-4
Synonyms: Tauroursodeoxycholic acid dihydrate; TUDCA dihydrate; UR 906 dihydrate
Tauroursodeoxycholate dehydrate is an orally active taurine conjugate of Ursodeoxycholic acid (HY-13771). Tauroursodeoxycholate dehydrate inhibits caspase-3/7, Apoptosis, IRE1α/TRAF2/NF-κB, prevents JNK phosphorylation, inhibits ROS generation, and activates Akt signaling. Tauroursodeoxycholate dehydrate prevents cataract formation, reduces renal tubular damage in type 2 diabetic mice, reduces I/R injury in liver, and inhibits intestinal inflammation and barrier disruption in nonalcoholic fatty liver disease [1] .
loading...
    loading...
108
108 Cited Publications
Cat. No.: HY-10255A
CAS No.: 557795-19-4
Purity:  99.04%
Synonyms: SU 11248
Research Areas:  

Cancer

Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively [1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
loading...
    loading...
108
108 Cited Publications
Cat. No.: HY-10255
CAS No.: 341031-54-7
Purity:  99.86%
Synonyms: SU 11248 Malate
Sunitinib (SU 11248) Malat is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively [1]. Sunitinib Malat, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
loading...
    loading...
108
108 Cited Publications
Cat. No.: HY-10255C
CAS No.: 1818285-48-1
Synonyms: SU 11248 glucuronate
Research Areas:  

Cancer

Sunitinib (SU 11248) glucuronate is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively [1]. Sunitinib glucuronate, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
loading...
    loading...
74
74 Cited Publications
Cat. No.: HY-19707
CAS No.: 14003-96-4
Synonyms: IRE1 Inhibitor III
Target:  

IRE1

Research Areas:  

Metabolic Disease

4μ8C (IRE1 Inhibitor III) is a small-molecule inhibitor of IRE1α.
loading...
    loading...
53
53 Cited Publications
Cat. No.: HY-15845
CAS No.: 307543-71-1
Purity:  ≥98.0%
Target:  

IRE1

Research Areas:  

Cancer

STF-083010 is a specific IRE1α inhibitor. STF-083010 inhibits Ire1 endonuclease activity, without affecting its kinase activity, after endoplasmic reticulum stress.
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-19708
CAS No.: 1589527-65-0
Target:  

IRE1

KIRA6 is an advanced small-molecule IRE1α RNase kinase inhibitor with an IC50 of 0.6 µM . KIRA6 can trigger an apoptotic response [1].
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-103248
CAS No.: 606-58-6
Purity:  99.78%
Synonyms: Vengicide
Toyocamycin (Vengicide) is an adenosine analog produced by Streptomyces diastatochromogenes, acts as an XBP1 inhibitor. Toyocamycin blocks RNA synthesis and ribosome function, and induces apoptosis. Toyocamycin affects IRE1α-XBP1 pathway, and inhibits XBP1 mRNA cleavage with an IC50 value of 80 nM with affecting IRE1α auto-phosphorylation. Toyocamycin specifically inhibits CDK9 with an IC50 value of 79 nM [1] .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-114368
CAS No.: 1630086-20-2
Purity:  98.90%
Synonyms: AMG-18
Target:  

IRE1

Research Areas:  

Inflammation/Immunology

Kira8 (AMG-18) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity with an IC50 of 5.9 nM [1].
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-114368A
CAS No.: 2250019-92-0
Synonyms: AMG-18 Hydrochloride
Target:  

IRE1

Research Areas:  

Inflammation/Immunology

Kira8 Hydrochloride (AMG-18 Hydrochloride) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity with an IC50 of 5.9 nM [1].
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-17537
CAS No.: 1216665-49-4
Target:  

IRE1

Research Areas:  

Cancer

APY29, an ATP-competitive inhibitor, is an allosteric modulator of IRE1α which inhibits IRE1α autophosphorylation by binding to the ATP-binding pocket with IC50 of 280 nM. APY29 acts as a ligand that allosterically activates IRE1α adjacent RNase domain [1].
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-19710
CAS No.: 1093119-54-0
Target:  

IRE1

Research Areas:  

Cancer

MKC3946 is a potent IRE1α inhibitor, used for cancer research.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-U00459
CAS No.: 2121989-91-9
Synonyms: GSK163
Target:  

IRE1

Research Areas:  

Cancer

GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit IRE1α kinase activity and RNase activity with IC50s of 20 and 200 nM, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N7030
CAS No.: 855-97-0
5,7,3',4'-Tetramethoxyflavone, an orally active polymethoxyflavones (PMFs) that can be isolated from M. exotica, possesses various bioactivities, including anti-fungal, anti-malarial, anti-mycobacterial, and anti-inflammatory activities. 5,7,3',4'-Tetramethoxyflavone exhibits chondroprotective activity by targeting β-catenin signaling [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136735
CAS No.: 2328097-41-0
Purity:  98.94%
Target:  

IRE1

Research Areas:  

Neurological Disease Cancer

IRE1α kinase-IN-1 is a highly selective IRE1α (ERN1) inhibitor, with an IC50 of 77 nM. IRE1α kinase-IN-1 displays 100-fold selectivity for IRE1α over the IRE1β isoform. IRE1α kinase-IN-1 inhibits ER stress-induced IRE1α oligomerization and autophosphorylation, and also inhibits IRE1α RNase activity (IC50=80 nM) [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18509
CAS No.: 1414938-21-8
Target:  

IRE1

Research Areas:  

Cancer

IRE1α kinase-IN-2 is a potent IRE1α kinase inhibitor, with an EC50 of 0.82 μM. IRE1α kinase-IN-2 inhibits IRE1α kinase autophosphorylation (IC50=3.12 μM). IRE1α kinase-IN-2 inhibits XBP1 mRNA splicing in the WT cell lines [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W018161
CAS No.: 505-54-4
Synonyms: Thapsic acid
Hexadecanedioic acid (Thapsic acid) is an orally active metabolite produced by B. uniformis. Hexadecanedioic acid inhibits IRE1α-XBP1s-mediated flipogenesis and ferroptosis. Hexadecanedioic acid downregulates XBP1 and Hrd1 expression, activates the Nrf2/SLC7A11/GPX4 pathway. Hexadecanedioic acid can be used for the research of metabolic-associated fatty liver disease [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12399
CAS No.: 1338934-20-5
Purity:  98.33%
Target:  

IRE1

Research Areas:  

Cancer

MKC9989 is a Hydroxy aryl aldehydes (HAA) inhibitor and also inhibits IRE1α with an IC50 of 0.23 to 44 μM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-U00460
Target:  

IRE1

Research Areas:  

Cancer

3,6-DMAD hydrochloride, an acridine derivative, is a potent IRE1α-XBP1s pathway inhibitor. 3,6-DMAD hydrochloride promotes IL-6 secretion via the IRE1α-XBP1s pathway. 3,6-DMAD hydrochloride inhibits IRE1α oligomerization and endoribonuclease (RNase) activity. 3,6-DMAD hydrochloride can be used for research of cancer [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80828
Synonyms: ERN1; IRE1; Serine/threonine-protein kinase/endoribonuclease IRE1; Endoplasmic reticulum-to-nucleus signaling 1; Inositol-requiring protein 1; hIRE1p; IRE1-alpha; IRE1a

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...